Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, USA.
J Biol Chem. 2012 Apr 6;287(15):12070-82. doi: 10.1074/jbc.M111.316463. Epub 2012 Feb 16.
The cannabinoid receptor 1 (CB1), a member of the class A G protein-coupled receptor family, is expressed in brain tissue where agonist stimulation primarily activates the pertussis toxin-sensitive inhibitory G protein (G(i)). Ligands such as CP55940 ((1R,3R,4R)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3- hydroxypropyl)cyclohexan-1-ol) and Δ(9)-tetrahydrocannabinol are orthosteric agonists for the receptor, bind the conventional binding pocket, and trigger G(i)-mediated effects including inhibition of adenylate cyclase. ORG27569 (5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)ethyl]amide) has been identified as an allosteric modulator that displays positive cooperativity for CP55940 binding to CB1 yet acts as an antagonist of G protein coupling. To examine this apparent conundrum, we used the wild-type CB1 and two mutants, T210A and T210I (D'Antona, A. M., Ahn, K. H., and Kendall, D. A. (2006) Biochemistry 45, 5606-5617), which collectively cover a spectrum of receptor states from inactive to partially active to more fully constitutively active. Using these receptors, we demonstrated that ORG27569 induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased inverse agonist affinity consistent with an active conformation. Also consistent with this conformation, the impact of ORG27569 binding was most dramatic on the inactive T210A receptor and less pronounced on the already active T210I receptor. Although ORG27569 antagonized CP55940-induced guanosine 5'-3-O-(thio)triphosphate binding, which is indicative of G protein coupling inhibition in a concentration-dependent manner, the ORG27569-induced conformational change of the CB1 receptor led to cellular internalization and downstream activation of ERK signaling, providing the first case of allosteric ligand-biased signaling via CB1. ORG27569-induced ERK phosphorylation persisted even after pertussis toxin treatment to abrogate G(i) and occurs in HEK293 and neuronal cells.
大麻素受体 1(CB1)是 A 类 G 蛋白偶联受体家族的成员,在脑组织中表达,激动剂刺激主要激活百日咳毒素敏感的抑制性 G 蛋白(G(i))。CP55940((1R,3R,4R)-3-[2-羟基-4-(1,1-二甲基庚基)苯基]-4-(3-羟基丙基)环己烷-1-醇)和 Δ(9)-四氢大麻酚等配体是该受体的正构激动剂,与常规结合口袋结合,并引发 G(i)介导的效应,包括抑制腺苷酸环化酶。ORG27569(5-氯-3-乙基-1H-吲哚-2-羧酸[2-(4-哌啶-1-基-苯基)乙基]酰胺)已被鉴定为一种变构调节剂,对 CP55940 与 CB1 的结合表现出正协同性,但作为 G 蛋白偶联的拮抗剂。为了研究这个明显的难题,我们使用了野生型 CB1 和两种突变体,T210A 和 T210I(D'Antona, A. M., Ahn, K. H., and Kendall, D. A. (2006) Biochemistry 45, 5606-5617),它们共同涵盖了从无活性到部分活性再到更完全组成性活性的受体状态谱。使用这些受体,我们证明 ORG27569 诱导 CB1 受体状态,其特征是增强激动剂亲和力和降低反向激动剂亲和力,与活性构象一致。这也与该构象一致,ORG27569 结合的影响在无活性的 T210A 受体上最为显著,在已经活性的 T210I 受体上则不那么明显。尽管 ORG27569 以浓度依赖的方式拮抗 CP55940 诱导的鸟苷 5'-3-O-(硫)三磷酸结合,这表明 G 蛋白偶联抑制,但 ORG27569 诱导的 CB1 受体构象变化导致细胞内化和下游 ERK 信号转导的激活,提供了通过 CB1 进行变构配体偏向信号转导的首例情况。即使在用百日咳毒素处理以消除 G(i)后,ORG27569 诱导的 ERK 磷酸化仍然存在,并发生在 HEK293 和神经元细胞中。